3-Thiazolidinecarboxamide, N-(3,4-dichlorophenyl)-2-[(4-fluorophenyl)imino]-5-methyl-
- CAS No.
- 2411853-34-2
- Chemical Name:
- 3-Thiazolidinecarboxamide, N-(3,4-dichlorophenyl)-2-[(4-fluorophenyl)imino]-5-methyl-
- Synonyms
- JR-AB2-011 ,E1151;JR-AB2-011, 10 mM in DMSO;JRAB2011,JR-AB-2-011,JR AB2 011;N-(3,4-Dichlorophenyl)-2-((4-fluorophenyl)imino)-5-methylthiazolidine-3-carboxamide;3-Thiazolidinecarboxamide, N-(3,4-dichlorophenyl)-2-[(4-fluorophenyl)imino]-5-methyl-
- CBNumber:
- CB98358531
- Molecular Formula:
- C17H14Cl2FN3OS
- Molecular Weight:
- 398.28
- MDL Number:
- MOL File:
- 2411853-34-2.mol
- MSDS File:
- SDS
- TDS File:
- TDS
| Density | 1.45±0.1 g/cm3(Predicted) |
|---|---|
| storage temp. | 2-8°C |
| solubility | Ethanol:3.0(Max Conc. mg/mL);7.53(Max Conc. mM) |
| form | Solid |
| pka | 11.58±0.70(Predicted) |
| color | White to off-white |
| UNSPSC Code | 12352200 |
| NACRES | NA.77 |
3-Thiazolidinecarboxamide, N-(3,4-dichlorophenyl)-2-[(4-fluorophenyl)imino]-5-methyl- price
| Manufacturer | Product number | Product description | CAS number | Packaging | Price | Updated | Buy |
|---|---|---|---|---|---|---|---|
| Sigma-Aldrich | SML3644 | JR-AB2-011 ≥98% (HPLC) | 2411853-34-2 | 5MG | $274 | 2026-04-30 | Buy |
| Sigma-Aldrich | SML3644 | JR-AB2-011 ≥98% (HPLC) | 2411853-34-2 | 25MG | $1110 | 2026-04-30 | Buy |
| Biosynth | LWD85334 | Jr-ab2-011 | 2411853-34-2 | 25mg | $1164.25 | 2026-06-04 | Buy |
| Biosynth | LWD85334 | Jr-ab2-011 | 2411853-34-2 | 50mg | $1620 | 2026-06-04 | Buy |
| ChemScene | CS-0081286 | JR-AB2-011 98.15% | 2411853-34-2 | 5mg | $282 | 2026-06-04 | Buy |
3-Thiazolidinecarboxamide, N-(3,4-dichlorophenyl)-2-[(4-fluorophenyl)imino]-5-methyl- Chemical Properties, Uses, Production
Uses
JR-AB2-011 is a selective mTORC2 inhibitor with an IC50 value of 0.36 μM. JR-AB2-011 inhibits mTORC2 activity by blocking Rictor-mTOR association (Ki: 0.19 μM)[1].JR-AB2-011 decreases the phosphorylation level of Akt, decreases MMP2 activity, thereby reducing the ability of tumor cells to migrate and invade. JR-AB2-011 also induces non-apoptotic cell death[2].
Biological Activity
JR-AB2-011 is a selective mTORC2 inhibitor th at blocks the interaction of Rictor and mTOR (IC50 = 0.31 μM) without affecing mTORC1 activity or assembly. JR-AB2-011 exhibits anti-glioblastoma (GBM) activity in vitro (proliferation IC50 = 0.31 μM post 72h treatment, 36.3% apoptosis post 48h 1 μM treatment in LN229 cultures) and in vivo (4 or 20 mg/kg/d i.p. to LN229 xenografted mice).
in vivo
Mice were subcutaneously implanted with tumor cells and when tumors were palpable (~200 mm3), mice were randomized into treatment groups receiving vehicle, JR-AB2-011 (4 mg/kg/d) and JR-AB2-011 (20 mg/kg/d). As shown in Fig 6A, mice receiving JR-AB2-011 at either dosing regimen displayed marked inhibition of tumor growth rate (JR-AB2-011 at 4 mg/kg/d; 74% inhibition at end of dosing period; tumor growth delay 10.0 days; JR-AB2-011 at 20 mg/kg/d; 80% inhibition at end of dosing period; tumor growth delay 12.0 days) as compared to mice receiving vehicle alone. Consistent with the effects on xenograft growth, overall survival of mice at either JR-AB2-011 dosing regimen was significantly extended relative to vehicle treated mice. _x000D_ _x000D_ Reference: PLoS One. 2017 Apr 28;12(4):e0176599. https://pubmed.ncbi.nlm.nih.gov/28453552/
target
JR-AB2-011 is a selective mTORC2 inhibitor with an IC50 value of 0.36 μM. JR-AB2-011 inhibits mTORC2 activity by blocking Rictor-mTOR association (Ki: 0.19 μM).
IC 50
mTORC2: 0.36 μM (IC50)
References
[1] Zhang A, et al. CCL17 exerts neuroprotection through activation of CCR4/mTORC2 axis in microglia after subarachnoid haemorrhage in rats. Stroke Vasc Neurol. 2022 Jul 26;8(1):4–16. DOI:10.1136/svn-2022-001659
[2] Guenzle J, et al. Pharmacological Inhibition of mTORC2 Reduces Migration and Metastasis in Melanoma. Int J Mol Sci. 2020 Dec 22;22(1):30
[3] Wu M, et al Dioscin ameliorates murine ulcerative colitis by regulating macrophage polarization. Pharmacol Res. 2021 Oct ; 172:105796 DOI:10.1016/j.phrs.2021.105796
3-Thiazolidinecarboxamide, N-(3,4-dichlorophenyl)-2-[(4-fluorophenyl)imino]-5-methyl- Preparation Products And Raw materials
Raw materials
Preparation Products
3-Thiazolidinecarboxamide, N-(3,4-dichlorophenyl)-2-[(4-fluorophenyl)imino]-5-methyl- Suppliers
| Supplier | Tel | Country | ProdList | Advantage | |
|---|---|---|---|---|---|
| BOC Sciences | 1-631-485-4226; 16314854226 | info@bocsci.com | United States | 9920 | 65 |
| Guangzhou Isun Pharmaceutical Co., Ltd | 020-39119399 18927568969 | isunpharm@qq.com | China | 4773 | 55 |
| Shanghai YuanYe Biotechnology Co., Ltd. | 15026964105 | 2881489226@qq.com | China | 89667 | 60 |
| Shanghai Chaolan Chemical Technology Center | QQ:65489617 13301690235 | Sales@ATKchemical.com | China | 9729 | 58 |
| TargetMol Chemicals Inc. | +1-781-999-5354; +1-00000000000 | marketing@targetmol.com | United States | 32431 | 58 |
| JinOu Biomedical (Nanjing) Co., Ltd. | 13000000000 | jinoupharma@163.com | China | 11706 | 58 |
| Bide Pharmatech Ltd. | 400-1647117 13681763483 | product02@bidepharm.com | China | 59929 | 58 |
| InvivoChem | 13549236410 | sales@invivochem.cn | China | 6745 | 58 |
| Beijing Biocreative Technology Co., Ltd. | 15522676233 | 3007606172@qq.com | China | 1246 | 58 |
| TargetMol Chemicals Inc. | 4008200310 15002144251 | marketing@tsbiochem.com | China | 24951 | 58 |
View Latest Price from 3-Thiazolidinecarboxamide, N-(3,4-dichlorophenyl)-2-[(4-fluorophenyl)imino]-5-methyl- manufacturers
| Image | Update time | Product | Price | Min. Order | Purity | Supply Ability | Manufacturer | |
|---|---|---|---|---|---|---|---|---|
![]() |
2026-07-27 | JR-AB2-011
2411853-34-2
|
$87.00-363.00 | 99.41% | 10g | TargetMol Chemicals Inc. | ||
![]() |
2026-07-27 | JR-AB2-011
2411853-34-2
|
$87.00-363.00 | 99.41% | 10g | TargetMol Chemicals Inc. |
-

- JR-AB2-011
2411853-34-2
- $87.00-363.00
- 99.41%
- TargetMol Chemicals Inc.
-

- JR-AB2-011
2411853-34-2
- $87.00-363.00
- 99.41%
- TargetMol Chemicals Inc.




